Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Carvedilol Phosphate. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Carvedilol can be increased when combined with Abatacept.
Level 1 evidence
Acarbose
The therapeutic efficacy of Acarbose can be increased when used in combination with Carvedilol.
Level 1 evidence
Acebutolol
Carvedilol may increase the arrhythmogenic activities of Acebutolol.
Level 1 evidence
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Carvedilol.
Level 1 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Carvedilol.
Level 2 evidence
Acetaminophen
Carvedilol may increase the hepatotoxic activities of Acetaminophen.
Level 1 evidence
Acetylcholine
The risk or severity of adverse effects can be increased when Carvedilol is combined with Acetylcholine.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the antihypertensive activities of Carvedilol.
Level 1 evidence
Acoramidis
The metabolism of Carvedilol can be decreased when combined with Acoramidis.
Level 2 evidence
Acyclovir
The metabolism of Carvedilol can be decreased when combined with Acyclovir.
Level 2 evidence
Adagrasib
The metabolism of Carvedilol can be decreased when combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Carvedilol can be increased when combined with Adalimumab.
Level 1 evidence
Enter your NPI to unlock 17 major interactions for Carvedilol Phosphate
Carvedilol Phosphate has 1147 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Carvedilol Phosphate has 166 major, 588 moderate, and 393 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Carvedilol Phosphate. Always confirm against the full prescribing information.